Lily Weckx
Overview
Explore the profile of Lily Weckx including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clemens S, Weckx L, Milan E, Smolenov I, Clemens R
Vaccine
. 2024 May;
42(19):3989-3998.
PMID: 38762360
Background: The COVID-19 pandemic is over but the highly immunized or naturally exposed global population still requires booster vaccinations against newly emerging SARS-CoV-2 variants. We assessed safety and immunogenicity of...
2.
Marchevsky N, Li G, Aley P, Clemens S, Barrett J, Belij-Rammerstorfer S, et al.
EBioMedicine
. 2022 Jul;
81:104128.
PMID: 35779491
Background: There are known differences in vaccine reactogenicity and immunogenicity by sex. Females have been shown to report greater reactogenicity and generate higher humoral and cellular immune responses than males...
3.
Clemens S, Weckx L, Clemens R, Mendes A, Ramos Souza A, Silveira M, et al.
Lancet
. 2022 Jan;
399(10324):521-529.
PMID: 35074136
Introduction: The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. We assessed whether a third dose of the homologous or a different vaccine could...
4.
Cancado B, Aranda C, Mallozi M, Weckx L, Sole D
Lancet Infect Dis
. 2019 Jul;
19(8):812.
PMID: 31345456
No abstract available.
5.
Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
J Infect
. 2016 Sep;
74(1):29-41.
PMID: 27667752
Background: Better population data on respiratory viruses in children in tropical and southern hemisphere countries is needed. Methods: The epidemiology of respiratory viruses among healthy children (6 months to <10...
6.
Cunningham A, Lal H, Kovac M, Chlibek R, Hwang S, Diez-Domingo J, et al.
N Engl J Med
. 2016 Sep;
375(11):1019-32.
PMID: 27626517
Background: A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vaccine (HZ/su) containing recombinant varicella-zoster virus glycoprotein E and the AS01B adjuvant...
7.
Lal H, Cunningham A, Godeaux O, Chlibek R, Diez-Domingo J, Hwang S, et al.
N Engl J Med
. 2015 Apr;
372(22):2087-96.
PMID: 25916341
Background: In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety...
8.
Nolan T, Borja-Tabora C, Lopez P, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
Clin Infect Dis
. 2015 Feb;
60(11):e80-9.
PMID: 25673560
Background: The high burden of respiratory syncytial virus (RSV)-associated morbidity and mortality makes vaccine development a priority. Methods: As part of an efficacy trial of pandemic influenza vaccines (NCT01051661), RSV...
9.
Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, et al.
J Infect Dis
. 2014 Mar;
210(4):545-57.
PMID: 24652494
Background: The vaccine efficacy (VE) of 1 or 2 doses of AS03-adjuvanted influenza A(H1N1) vaccine relative to that of 2 doses of nonadjuvanted influenza A(H1N1) vaccine in children 6 months...